CARB-X global partnership headed toward developing an innovative vaccine against potentially deadly Staphylococcus aureus bacteria that could be a “game
IBT CEO Dr. M. Javad Aman will discuss the development of a multi-component toxoid vaccine for S. aureus and the
[Rockville, MD, April 2025] A promising new therapeutic is being
IBT Bioservices Transforms Identity, Elevates Focus on Contract Research Services
CARB-X global partnership headed toward developing an innovative vaccine against
Subscribe to the IBT Bioservices Tech Talk list and receive periodic updates on industry news and IBT Bioservices products and services.
For Product Information,
Orders & Technical Support
products@integratedbiotherapeutics.com
For Services
services@ibtbioservices.com
